Works by Hatta, Yoshihiro


Results: 93
    1

    Introducing heat-not-burn tobacco improves hematocrit and cigarette smoking-related symptoms in patients with smokers' polycythemia and polycythemia vera.

    Published in:
    PLoS ONE, 2025, v. 20, n. 5, p. 1, doi. 10.1371/journal.pone.0323437
    By:
    • Iizuka, Kazuhide;
    • Iizuka, Yoshikazu;
    • Ito, Shun;
    • Endo, Toshihide;
    • Nukariya, Hironao;
    • Takeuchi, Yuichi;
    • Koike, Takashi;
    • Kurihara, Kazuya;
    • Takahashi, Hiromichi;
    • Nakagawa, Masaru;
    • Hamada, Takashi;
    • Ohtake, Shimon;
    • Iriyama, Noriyoshi;
    • Miura, Katsuhiro;
    • Nakayama, Tomohiro;
    • Hatta, Yoshihiro;
    • Nakamura, Hideki;
    • Komatsu, Norio
    Publication type:
    Article
    2

    Harmonization of molecular monitoring of chronic myeloid leukemia therapy in Japan.

    Published in:
    International Journal of Clinical Oncology, 2012, v. 17, n. 6, p. 584, doi. 10.1007/s10147-011-0328-x
    By:
    • Yoshida, Chikashi;
    • Fletcher, Linda;
    • Ohashi, Kazuteru;
    • Wakita, Hisashi;
    • Kumagai, Takashi;
    • Shiseki, Masayuki;
    • Matsuei, Kousei;
    • Inokuchi, Koiti;
    • Hatta, Yoshihiro;
    • Shirasugi, Yukari;
    • Yamaguchi, Toshikazu;
    • Sakamoto, Junichi;
    • Branford, Susan;
    • Sakamaki, Hisashi
    Publication type:
    Article
    3
    4
    5
    6
    7
    8
    9
    10

    Pirarubicin‐based intensive chemotherapy followed by consolidative high‐dose chemotherapies for peripheral T‐cell lymphomas: A noncomparative phase 2 study.

    Published in:
    Hematological Oncology, 2022, v. 40, n. 5, p. 1094, doi. 10.1002/hon.3043
    By:
    • Takahashi, Hiromichi;
    • Miura, Katsuhiro;
    • Nakagawa, Masaru;
    • Nishimaki, Haruna;
    • Ito, Shun;
    • Nukariya, Hironao;
    • Kurihara, Kazuya;
    • Endo, Toshihide;
    • Koike, Takashi;
    • Hamada, Takashi;
    • Iizuka, Kazuhide;
    • Ohatake, Shimon;
    • Iriyama, Noriyoshi;
    • Nakayama, Tomohiro;
    • Masuda, Shinobu;
    • Hatta, Yoshihiro;
    • Nakamura, Hideki
    Publication type:
    Article
    11

    Consolidation with <sup>90</sup>Yttrium‐ibritumomab tiuxetan after bendamustine and rituximab for relapsed follicular lymphoma.

    Published in:
    Hematological Oncology, 2021, v. 39, n. 1, p. 51, doi. 10.1002/hon.2809
    By:
    • Miura, Katsuhiro;
    • Tsujimura, Hideki;
    • Masaki, Yasufumi;
    • Iino, Masaki;
    • Takizawa, Jun;
    • Maeda, Yoshinobu;
    • Yamamoto, Kazuhiko;
    • Tamura, Shinobu;
    • Yoshida, Akiyo;
    • Yagi, Hideo;
    • Yoshida, Isao;
    • Kitazume, Koichi;
    • Masunari, Taro;
    • Choi, Ilseung;
    • Kakinoki, Yasutaka;
    • Suzuki, Ritsuro;
    • Yoshino, Tadashi;
    • Nakamura, Shigeo;
    • Hatta, Yoshihiro;
    • Yoshida, Takashi
    Publication type:
    Article
    12
    13
    14

    Outcomes of adolescents and young adults with chronic-phase chronic myeloid leukaemia treated with tyrosine kinase inhibitors.

    Published in:
    Annals of Medicine, 2022, v. 54, n. 1, p. 1244, doi. 10.1080/07853890.2022.2069280
    By:
    • Nishiyama-Fujita, Yuriko;
    • Nakazato, Tomonori;
    • Iriyama, Noriyoshi;
    • Tokuhira, Michihide;
    • Ishikawa, Maho;
    • Sato, Eriko;
    • Takaku, Tomoiku;
    • Sugimoto, Keiji;
    • Fujita, Hiroyuki;
    • Fujioka, Isao;
    • Tsuchiya, Shun;
    • Kimura, Yuta;
    • Iwanaga, Eisaku;
    • Komatsu, Norio;
    • Asou, Norio;
    • Kizaki, Masahiro;
    • Hatta, Yoshihiro;
    • Kawaguchi, Tatsuya
    Publication type:
    Article
    15
    16

    Fostamatinib for the treatment of Japanese patients with primary immune thrombocytopenia: A phase 3, placebo‐controlled, double‐blind, parallel‐group study.

    Published in:
    British Journal of Haematology, 2023, v. 200, n. 6, p. 802, doi. 10.1111/bjh.18582
    By:
    • Kuwana, Masataka;
    • Ito, Tomoki;
    • Kowata, Shugo;
    • Hatta, Yoshihiro;
    • Fujimaki, Katsumichi;
    • Naito, Kensuke;
    • Kurahashi, Shingo;
    • Kagoo, Toshiya;
    • Tanimoto, Kazuki;
    • Saotome, So;
    • Tomiyama, Yoshiaki;
    • Koike, Michiaki;
    • Nakajima, Yuki;
    • Harada, Hiroshi;
    • Hangaishi, Akira;
    • Yokoyama, Kenji;
    • Cho, Ryuko;
    • Kyoda, Katsunori;
    • Kakinoki, Yasutaka;
    • Yoshida, Masahiro
    Publication type:
    Article
    17

    Macrophage depletion using clodronate liposomes reveals latent dysfunction of the hematopoietic microenvironment associated with persistently imbalanced M1/M2 macrophage polarization in a mouse model of hemophagocytic lymphohistiocytosis.

    Published in:
    Annals of Hematology, 2023, v. 102, n. 12, p. 3311, doi. 10.1007/s00277-023-05425-w
    By:
    • Koike, Takashi;
    • Miura, Katsuhiro;
    • Hatta, Yoshihiro;
    • Nakamura, Hideki;
    • Hirabayashi, Yoko;
    • Yuda, Miyuki;
    • Harada, Tomonori;
    • Hirai, Shuichi;
    • Tsuboi, Isao;
    • Aizawa, Shin
    Publication type:
    Article
    18
    19
    20
    21
    22
    23
    24

    Nelarabine‐combined chemotherapy improves outcome of T‐cell acute lymphoblastic leukemia but shows more severe neurotoxicity: JALSG T‐ALL213‐O.

    Published in:
    Cancer Science, 2025, v. 116, n. 2, p. 453, doi. 10.1111/cas.16405
    By:
    • Hayakawa, Fumihiko;
    • Mori, Naoki;
    • Imai, Kiyotoshi;
    • Yokoyama, Yasuhisa;
    • Katsuoka, Yuna;
    • Saito, Takeshi;
    • Murayama, Tohru;
    • Yamazaki, Etsuko;
    • Sato, Shinya;
    • Atsuta, Yoshiko;
    • Ishikawa, Yuichi;
    • Sakaida, Emiko;
    • Hatta, Yoshihiro;
    • Matsumura, Itaru;
    • Miyazaki, Yasushi;
    • Kiyoi, Hitoshi;
    • Jinnai, Itsuro;
    • Sugiura, Isamu;
    • Yasunami, Takeshi;
    • Sakura, Toru
    Publication type:
    Article
    25

    Central nervous system event in patients with diffuse large B-cell lymphoma in the rituximab era.

    Published in:
    Cancer Science, 2012, v. 103, n. 2, p. 245, doi. 10.1111/j.1349-7006.2011.02139.x
    By:
    • Tomita, Naoto;
    • Yokoyama, Masahiro;
    • Yamamoto, Wataru;
    • Watanabe, Reina;
    • Shimazu, Yutaka;
    • Masaki, Yasufumi;
    • Tsunoda, Saburo;
    • Hashimoto, Chizuko;
    • Murayama, Kayoko;
    • Yano, Takahiro;
    • Okamoto, Rumiko;
    • Kikuchi, Ako;
    • Tamura, Kazuo;
    • Sato, Kazuya;
    • Sunami, Kazutaka;
    • Shibayama, Hirohiko;
    • Takimoto, Rishu;
    • Ohshima, Rika;
    • Hatta, Yoshihiro;
    • Moriuchi, Yukiyoshi
    Publication type:
    Article
    26
    27

    Mycotic pseudoaneurysm of a pulmonary artery branch caused by Cladosporium.

    Published in:
    Pathology International, 2018, v. 68, n. 1, p. 47, doi. 10.1111/pin.12615
    By:
    • Sunagawa, Keishin;
    • Uchino, Yoshihito;
    • Ishimoto, Shinichirou;
    • Nakamura, Shigeki;
    • Honma, Taku;
    • Nakanishi, Yoko;
    • Hatta, Yoshihiro;
    • Miyazaki, Yoshitsugu;
    • Sakurai, Hiroyuki;
    • Hao, Hiroyuki;
    • Sugitani, Masahiko
    Publication type:
    Article
    28

    Contemporary management of diffuse large B-cell lymphoma in Japan.

    Published in:
    Expert Review of Anticancer Therapy, 2025, v. 25, n. 5, p. 551, doi. 10.1080/14737140.2025.2490283
    By:
    • Miura, Katsuhiro;
    • Takahashi, Hiromichi;
    • Nishimaki-Watanabe, Haruna;
    • Hamada, Takashi;
    • Uchiike, Akihiro;
    • Tsutsumi, Daisuke;
    • Ohtake, Shimon;
    • Iizuka, Kazuhide;
    • Koike, Takashi;
    • Kurihara, Kazuya;
    • Endo, Toshihide;
    • Hayama, Tatsuya;
    • Nakagawa, Masaru;
    • Iriyama, Noriyoshi;
    • Hatta, Yoshihiro;
    • Nakamura, Hideki
    Publication type:
    Article
    29

    Ideal dose intensity of R-CHOP in diffuse large B-cell lymphoma.

    Published in:
    Expert Review of Anticancer Therapy, 2022, v. 22, n. 6, p. 583, doi. 10.1080/14737140.2022.2071262
    By:
    • Miura, Katsuhiro;
    • Takahashi, Hiromichi;
    • Nakagawa, Masaru;
    • Hamada, Takashi;
    • Uchino, Yoshihito;
    • Iizuka, Kazuhide;
    • Ohtake, Shimon;
    • Iriyama, Noriyoshi;
    • Hatta, Yoshihiro;
    • Nakamura, Hideki
    Publication type:
    Article
    30
    31
    32
    33
    34

    Features of vascular adverse events in Japanese patients with chronic myeloid leukemia treated with tyrosine kinase inhibitors: a retrospective study of the CML Cooperative Study Group database.

    Published in:
    Annals of Hematology, 2018, v. 97, n. 11, p. 2081, doi. 10.1007/s00277-018-3412-8
    By:
    • Fujioka, Isao;
    • Takaku, Tomoiku;
    • Iriyama, Noriyoshi;
    • Tokuhira, Michihide;
    • Kimura, Yuta;
    • Sato, Eriko;
    • Ishikawa, Maho;
    • Nakazato, Tomonori;
    • Sugimoto, Kei-Ji;
    • Fujita, Hiroyuki;
    • Asou, Norio;
    • Kizaki, Masahiro;
    • Hatta, Yoshihiro;
    • Komatsu, Norio;
    • Kawaguchi, Tatsuya
    Publication type:
    Article
    35
    36

    Normal karyotype acute myeloid leukemia with the CD7+ CD15+ CD34+ HLA-DR + immunophenotype is a clinically distinct entity with a favorable outcome.

    Published in:
    Annals of Hematology, 2014, v. 93, n. 6, p. 957, doi. 10.1007/s00277-014-2013-4
    By:
    • Iriyama, Noriyoshi;
    • Asou, Norio;
    • Miyazaki, Yasushi;
    • Yamaguchi, Shunichiro;
    • Sato, Shinya;
    • Sakura, Toru;
    • Maeda, Tomoya;
    • Handa, Hiroshi;
    • Takahashi, Masatomo;
    • Ohtake, Shigeki;
    • Hatta, Yoshihiro;
    • Sakamaki, Hisashi;
    • Honda, Sumihisa;
    • Taki, Tomohiko;
    • Taniwaki, Masafumi;
    • Miyawaki, Shuichi;
    • Ohnishi, Kazunori;
    • Kobayashi, Yukio;
    • Naoe, Tomoki
    Publication type:
    Article
    37
    38

    Efficacy of Oral Cytarabine Ocfosfate and Etoposide in the Treatment of Elderly Patients with Higher-Risk Myelodysplastic Syndromes Compared to That in Elderly Acute Myeloid Leukemia Patients.

    Published in:
    Chemotherapy (0009-3157), 2013, v. 59, n. 2, p. 152, doi. 10.1159/000351114
    By:
    • Horikoshi, Akira;
    • Iriyama, Noriyoshi;
    • Hirabayashi, Yukio;
    • Kodaira, Hitomi;
    • Matsukawa, Yoshihiro;
    • Uchino, Yoshihito;
    • Takahashi, Hiromichi;
    • Hatta, Yoshihiro;
    • Takeuchi, Jin;
    • Kobayashi, Sumiko;
    • Miura, Katsuhiro
    Publication type:
    Article
    39

    The EUTOS long‐term survival score predicts disease‐specific mortality and molecular responses among patients with chronic myeloid leukemia in a practice‐based cohort.

    Published in:
    Cancer Medicine, 2020, v. 9, n. 23, p. 8931, doi. 10.1002/cam4.3516
    By:
    • Sato, Eriko;
    • Iriyama, Noriyoshi;
    • Tokuhira, Michihide;
    • Takaku, Tomoiku;
    • Ishikawa, Maho;
    • Nakazato, Tomonori;
    • Sugimoto, Kei‐Ji;
    • Fujita, Hiroyuki;
    • Kimura, Yuta;
    • Fujioka, Isao;
    • Asou, Norio;
    • Komatsu, Norio;
    • Kizaki, Masahiro;
    • Hatta, Yoshihiro;
    • Kawaguchi, Tatsuya
    Publication type:
    Article
    40
    41
    42
    43

    Potential role for second-generation tyrosine kinase inhibitors in patients with chronic myeloid leukemia harboring additional clonal chromosome abnormalities: A retrospective CML Cooperative Study Group analysis.

    Published in:
    Oncology Reports, 2019, v. 42, n. 6, p. 2836, doi. 10.3892/or.2019.7339
    By:
    • Ishikawa, Maho;
    • Iriyama, Noriyoshi;
    • Tokuhira, Michihide;
    • Takaku, Tomoiku;
    • Sato, Eriko;
    • Sugimoto, Kei-Ji;
    • Nakazato, Tomonori;
    • Fujita, Hiroyuki;
    • Kimura, Yuta;
    • Fujioka, Isao;
    • Komatsu, Norio;
    • Asou, Norio;
    • Kizaki, Masahiro;
    • Hatta, Yoshihiro;
    • Kawaguchi, Tatsuya
    Publication type:
    Article
    44

    Copper deficiency anaemia.

    Published in:
    British Journal of Haematology, 2014, v. 164, n. 2, p. 161, doi. 10.1111/bjh.12577
    By:
    • Kobayashi, Yujin;
    • Hatta, Yoshihiro
    Publication type:
    Article
    45

    Outcome after first relapse in adult patients with Philadelphia chromosome-negative acute lymphoblastic leukaemia.

    Published in:
    British Journal of Haematology, 2013, v. 161, n. 1, p. 95, doi. 10.1111/bjh.12225
    By:
    • Kako, Shinichi;
    • Kanamori, Heiwa;
    • Kobayashi, Naoki;
    • Shigematsu, Akio;
    • Nannya, Yasuhito;
    • Nakamae, Mika;
    • Shigeno, Kazuyuki;
    • Suzukawa, Kazumi;
    • Takeuchi, Masahiro;
    • Tsuzuki, Motohiro;
    • Usuki, Kensuke;
    • Hatanaka, Kazuo;
    • Ogawa, Kazuei;
    • Mitani, Kinuko;
    • Nawa, Yuichiro;
    • Hatta, Yoshihiro;
    • Mizuno, Ishikazu;
    • Kanda, Yoshinobu
    Publication type:
    Article
    46
    47
    48

    von Willebrand factor activity levels are influenced by driver mutation status in polycythemia vera and essential thrombocythemia patients with well‐controlled platelet counts.

    Published in:
    European Journal of Haematology, 2022, v. 109, n. 6, p. 779, doi. 10.1111/ejh.13866
    By:
    • Iizuka, Kazuhide;
    • Morishita, Soji;
    • Nishizaki, Yuji;
    • Iizuka, Yoshikazu;
    • Iriyama, Noriyoshi;
    • Ochiai, Tomonori;
    • Yanagisawa, Naotake;
    • Yasuda, Hajime;
    • Ando, Jun;
    • Gotoh, Akihiko;
    • Takei, Masami;
    • Hatta, Yoshihiro;
    • Nakamura, Hideki;
    • Nakayama, Tomohiro;
    • Komatsu, Norio
    Publication type:
    Article
    49

    Management and Risk Factors for Pleural Effusion in Japanese Patients with Chronic Myeloid Leukemia Treated with First-line Dasatinib in Real-world Clinical Practice.

    Published in:
    Internal Medicine, 2023, v. 62, n. 22, p. 3299, doi. 10.2169/internalmedicine.1611-23
    By:
    • Shun Tsuchiya;
    • Tomoiku Takaku;
    • Naoki Watanabe;
    • Noriyoshi Iriyama;
    • Yuta Kimura;
    • Eisaku Iwanaga;
    • Kei-ji Sugimoto;
    • Toru Mitsumori;
    • Maho Ishikawa;
    • Tomonori Nakazato;
    • Hiroyuki Fujita;
    • Eriko Sato;
    • Yoshihiro Hatta;
    • Norio Asou;
    • Masahiro Kizaki;
    • Michihide Tokuhira;
    • Miki Ando;
    • Tatsuya Kawaguchi
    Publication type:
    Article
    50